,src,lang,text
0,"











Cancer Drug Antitrust Claims
06 Nov 2019, 08:23 by BRIEF
NEW YORK – The Second Circuit ruled that a Russian pharmaceutical firm’s antitrust claims were barred by the Foreign Trade Antitrust Improvements Act, because the alleged price-fixing and kickbacks aimed at thwarting the firm’s U.S. launch of cancer-treatment drugs occurred in Russia. 

Return To Top



Columns


Law


National


Regional


International


About Us


Terms of Use


Privacy Policy


Masthead


Copyright © 2019 courthousenews.com


",en,"











Cancer Drug Antitrust Claims
06 Nov 2019, 08:23 by BRIEF
NEW YORK – The Second Circuit ruled that a Russian pharmaceutical firm’s antitrust claims were barred by the Foreign Trade Antitrust Improvements Act, because the alleged price-fixing and kickbacks aimed at thwarting the firm’s U.S. launch of cancer-treatment drugs occurred in Russia. 

Return To Top



Columns


Law


National


Regional


International


About Us


Terms of Use


Privacy Policy


Masthead


Copyright © 2019 courthousenews.com


"
